LCE2B

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, LCE2B mutation is significantly associated with the immune_cell of many other genes, with 4 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible LCE2B-associated genes across cancer lineages are Erythrocytes, CMP, and CD4+ T-cells. Each is linked with LCE2B in more than 1 cancer types. Because this analysis shows association rather than direction, both LCE2B-to-partner and partner-to-LCE2B results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Erythrocytes grouped by LCE2B-low versus LCE2B-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (LCE2B→partner) and Y-score (partner→LCE2B) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECErythrocytes →+0.033+2.879.010.03332
UCECCMP →+0.042+2.180.008.03622
UCECCD4+ T-cells →+0.005+4.744<.001.04031
UCEClymphatic Endothelial cells →-0.026-3.268.035.01111
Each partner links to its Q-omics profile. Showing the 4 strongest of 4 associations by consensus.

Erythrocytes by LCE2B expression — UCEC

Box plot of Erythrocytes in LCE2B-low vs LCE2B-high samples in UCEC.

Explore this box plot interactively →

Exploration